Ultimovacs is an immunotherapy company developing immune-stimulatory vaccines to treat a broad range of cancers.
— Sachs Associates (@SachsAssociates) February 24, 2023
Meet Ultimovacs at #Sachs_ELSF
More info @ https://t.co/hgPC4hxz57#Sachs_ELSF #SSLSW #lifesciences #partnering #bd #licensing pic.twitter.com/vNsZzj4zUm